Publication
Urinary Tract Effects of HPSE2 Mutations
dc.contributor.author | Stuart, H | |
dc.contributor.author | Roberts, N | |
dc.contributor.author | Hilton, E | |
dc.contributor.author | McKenzie, E | |
dc.contributor.author | Daly, S | |
dc.contributor.author | Hadfield, K | |
dc.contributor.author | Rahal, J | |
dc.contributor.author | Gardiner, N | |
dc.contributor.author | Tanley, S | |
dc.contributor.author | Lewis, M | |
dc.contributor.author | Sites, E | |
dc.contributor.author | Angle, B | |
dc.contributor.author | Alves, C | |
dc.contributor.author | Lourenço, T | |
dc.contributor.author | Rodrigues, M | |
dc.contributor.author | Calado, A | |
dc.contributor.author | Amado, M | |
dc.contributor.author | Guerreiro, N | |
dc.contributor.author | Serras, I | |
dc.contributor.author | Beetz, C | |
dc.contributor.author | Varga, R | |
dc.contributor.author | Silay, M | |
dc.contributor.author | Darlow, J | |
dc.contributor.author | Dobson, M | |
dc.contributor.author | Barton, D | |
dc.contributor.author | Hunziker, M | |
dc.contributor.author | Puri, P | |
dc.contributor.author | Feather, S | |
dc.contributor.author | Goodship, J | |
dc.contributor.author | Goodship, T | |
dc.contributor.author | Lambert, H | |
dc.contributor.author | Cordell, H | |
dc.contributor.author | Saggar, A | |
dc.contributor.author | Kinali, M | |
dc.contributor.author | Lorenz, C | |
dc.contributor.author | Moeller, K | |
dc.contributor.author | Schaefer, F | |
dc.contributor.author | Bayazit, A | |
dc.contributor.author | Weber, S | |
dc.contributor.author | Newman, W | |
dc.contributor.author | Woolf, A | |
dc.date.accessioned | 2016-05-24T14:14:29Z | |
dc.date.available | 2016-05-24T14:14:29Z | |
dc.date.issued | 2015-04 | |
dc.description.abstract | Urofacial syndrome (UFS) is an autosomal recessive congenital disease featuring grimacing and incomplete bladder emptying. Mutations of HPSE2, encoding heparanase 2, a heparanase 1 inhibitor, occur in UFS, but knowledge about the HPSE2 mutation spectrum is limited. Here, seven UFS kindreds with HPSE2 mutations are presented, including one with deleted asparagine 254, suggesting a role for this amino acid, which is conserved in vertebrate orthologs. HPSE2 mutations were absent in 23 non-neurogenic neurogenic bladder probands and, of 439 families with nonsyndromic vesicoureteric reflux, only one carried a putative pathogenic HPSE2 variant. Homozygous Hpse2 mutant mouse bladders contained urine more often than did wild-type organs, phenocopying human UFS. Pelvic ganglia neural cell bodies contained heparanase 1, heparanase 2, and leucine-rich repeats and immunoglobulin-like domains-2 (LRIG2), which is mutated in certain UFS families. In conclusion, heparanase 2 is an autonomic neural protein implicated in bladder emptying, but HPSE2 variants are uncommon in urinary diseases resembling UFS. | pt_PT |
dc.identifier.citation | J Am Soc Nephrol. 2015 Apr;26(4):797-804 | pt_PT |
dc.identifier.doi | 10.1681/ASN.2013090961 | pt_PT |
dc.identifier.uri | http://hdl.handle.net/10400.17/2500 | |
dc.language.iso | eng | pt_PT |
dc.peerreviewed | yes | pt_PT |
dc.publisher | American Society of Nephrology | pt_PT |
dc.subject | Animals | pt_PT |
dc.subject | Facies | pt_PT |
dc.subject | Female | pt_PT |
dc.subject | Glucuronidase | pt_PT |
dc.subject | Humans | pt_PT |
dc.subject | Male | pt_PT |
dc.subject | Mice | pt_PT |
dc.subject | Mice, Inbred C57BL | pt_PT |
dc.subject | Mutation | pt_PT |
dc.subject | Urinary Tract | pt_PT |
dc.subject | Urologic Diseases | pt_PT |
dc.subject | HDE GEN | pt_PT |
dc.title | Urinary Tract Effects of HPSE2 Mutations | pt_PT |
dc.type | journal article | |
dspace.entity.type | Publication | |
oaire.citation.endPage | 804 | pt_PT |
oaire.citation.issue | 4 | pt_PT |
oaire.citation.startPage | 797 | pt_PT |
oaire.citation.title | Journal of the American Society of Nephrology : JASN | pt_PT |
oaire.citation.volume | 26 | pt_PT |
rcaap.rights | openAccess | pt_PT |
rcaap.type | article | pt_PT |